
Titan Pharmaceuticals Announces Notification of FDA Action Date Extension for Probuphine
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/19/16 -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that the U.S. Food and Drug Administration (FDA) has notified Titan and its development and commercialization partner Braeburn …